FDA Recalls Mupirocin Ointment Due to Temperature Control Deviations
Mupirocin Ointment distributed nationwide is being recalled due to temperature abuse violations during manufacturing. Consumers with affected supplies should contact their pharmacy or healthcare provider for guidance.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II recall with no reported illnesses, injuries, or hospitalizations. While temperature abuse during distribution could compromise drug quality and efficacy, no actual harm has been documented, making this a precautionary quality control recall.
Plain-English summary
McKesson Medical-Surgical Inc. is recalling Mupirocin Ointment, USP 2% (NDC 0093-1010-42), a topical prescription antibiotic supplied in 22-gram tubes. The product was manufactured by Teva Pharmaceuticals USA, Inc.
The recall was initiated due to cGMP (current Good Manufacturing Practice) deviations involving temperature abuse during distribution. Improper temperature control during storage and shipment may compromise the product's quality and efficacy.
The affected product was distributed nationwide to healthcare facilities and pharmacies. Because lot numbers cannot be specifically identified for individual consignees, customers should review distribution dates provided in individual recall notifications.
Consumers and healthcare providers who have received potentially affected Mupirocin Ointment should contact their pharmacy or healthcare provider. The product should not be used if there is uncertainty about whether it was stored under proper temperature conditions.
The recalled product
- Product
- MUPIROCIN (MUPIROCIN)
- Brand
- MUPIROCIN
- Manufacturer
- Mckesson Medical-Surgical Inc. Corporate Office
- Category
- Drug — Topical Antibiotic
- Hazard
- temperature-abuse
- reduced-efficacy
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · MUPIROCIN
- HighMupirocin Antibiotic Ointment Recalled Nationwide Due to Subpotency
FDA (Drugs) · 2024-10-02
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27